Sumitomo Dainippon Pharma

Sumitomo Dainippon Pharma is a pharmaceutical company based in Japan. Founded in 2005, the company focuses on research and development of drugs for a wide range of therapeutic areas including central nervous system disorders, oncology, and infectious diseases. They have developed medications for the treatment of conditions such as schizophrenia, depression, bipolar disorder, and Parkinson's disease, among others. Additionally, Sumitomo Dainippon Pharma is also involved in the development of novel therapies for cancer and infectious diseases.